Enveric Biosciences, Inc.
ENVB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000890821
No open-market purchases or sales by Enveric Biosciences, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $736.8K in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Enveric Biosciences, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 15 | 15 | 0 |
| Shares | 222.9K | 489.3K | +266.4K (+119.6%) |
| Value | $518.3K | $635.8K | +$117.4K (+22.7%) |
New holders (2)
Institutions that held Enveric Biosciences, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 273,000 | $354.9K | 0.01% |
| ORG Partners LLC | 10 | $13 | 0.00% |
Sold out (2)
Institutions that held Enveric Biosciences, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Toronto Dominion Bank | 54 | $129 |
| Highlander Capital Management, LLC | 1 | $0 |